Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC reduced its position in Schrödinger, Inc. (NASDAQ:SDGR) by 75.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,304 shares of the company’s stock after selling 9,914 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Schrödinger were worth $64,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Avanza Fonder AB purchased a new position in shares of Schrödinger during the 4th quarter worth $577,000. Barclays PLC raised its holdings in shares of Schrödinger by 421.6% during the 3rd quarter. Barclays PLC now owns 107,554 shares of the company’s stock worth $1,995,000 after acquiring an additional 86,933 shares during the period. Raymond James Financial Inc. purchased a new position in shares of Schrödinger during the 4th quarter worth $325,000. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Schrödinger by 60.2% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,510,518 shares of the company’s stock worth $67,718,000 after acquiring an additional 1,319,464 shares during the period. Finally, Amundi raised its holdings in shares of Schrödinger by 197.7% during the 4th quarter. Amundi now owns 26,753 shares of the company’s stock worth $544,000 after acquiring an additional 17,766 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Schrödinger

In other news, insider Karen Akinsanya sold 16,723 shares of the stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $25.09, for a total value of $419,580.07. Following the completion of the sale, the insider now owns 15,625 shares in the company, valued at approximately $392,031.25. This trade represents a 51.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Geoffrey Craig Porges sold 5,491 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $21.76, for a total value of $119,484.16. Following the completion of the sale, the chief financial officer now owns 27,544 shares of the company’s stock, valued at approximately $599,357.44. This trade represents a 16.62% decrease in their position. The disclosure for this sale can be found here. Company insiders own 8.60% of the company’s stock.

Analyst Ratings Changes

SDGR has been the subject of a number of recent analyst reports. KeyCorp raised their price objective on Schrödinger from $30.00 to $32.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 16th. Piper Sandler cut their price objective on Schrödinger from $50.00 to $45.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $32.80.

Schrödinger Stock Performance

Schrödinger stock opened at $23.90 on Monday. The firm has a market capitalization of $1.75 billion, a price-to-earnings ratio of -10.21 and a beta of 1.84. Schrödinger, Inc. has a fifty-two week low of $16.60 and a fifty-two week high of $28.47. The stock’s fifty day moving average is $22.62 and its two-hundred day moving average is $21.82.

Schrödinger (NASDAQ:SDGR) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.01). Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The company had revenue of $59.55 million during the quarter, compared to analysts’ expectations of $54.60 million. During the same quarter in the prior year, the company earned ($0.86) earnings per share. The firm’s revenue was up 62.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.